Agenus Inc. - Special Call Transcript
I think we have a full house, and we are ready to start. Thank you very much for attending this session. The last time we had an R&D Day was in May of 2015. And as you'll see today, there's a lot that has happened. In 2015, we were transitioning into a fully burdened, if you will, what's called now an immuno-oncology company. And what I'll start with is, of course, the disclaimers, which I need not elaborate on what this means. It's the hypocrisy of the system that can say we can lie all we want and you can't sue us. That's what this statement says, unfortunately.
(inaudible)
That's right. I'm Garo Armen. I founded the company 25 years ago. And we have been in the business of immunology of cancer for the last 25 years. We have a very exciting program today. Some very distinguished guests that are under the ice. Heads of different cancer centers and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |